Leila Essid, Elise Boudousq, David Guillier, Narcisse Zwetyenga, Alain Tchurukdichian
{"title":"Efficacité de la prothèse trapézo-métacarpienne Touch® dans le traitement de la rhizarthrose : étude rétrospective à 5 ans","authors":"Leila Essid, Elise Boudousq, David Guillier, Narcisse Zwetyenga, Alain Tchurukdichian","doi":"10.1016/j.hansur.2024.101821","DOIUrl":null,"url":null,"abstract":"<div><div>Trapezometacarpal Osteoarthritis or rhizarthrosis, is a frequent osteoarthrosis of the base of the thumb. The total joint replacement represents an interesting surgical option for its treatment. The double-mobility Touch® prosthesis is available for several years and only few studies have been published to evaluate the safety and efficiency of this prosthesis in the long term. The objective of this study is to describe the outcomes of the Touch prosthesis for a minimal 5 years follow-up.</div><div>Patients who received a Touch prosthesis in the two investigational centers between March 2016 and July 2018, and with a 5 years follow up, were included in this retrospective and non-comparative study.</div><div>From 111 patients screened, 74 patients were included of which 8 had surgery at both sides. The mean age at the time of surgery was 62.4 (± 7.3) years. 62 (83.8%) were women and 51.2% of the patients had their dominant hand operated. The pain (VAS), Grip and Key pinch were significantly improved at five years follow-up. The quick DASH decreased from 55.1 to 14.6. The Kapandji opposition and retropulsion, the MCP active mobility flexion and extension improved. 91.3% of the patients are satisfied. 19 (23.2%) adverse events were minor and 8 (9.8%) were major. The most common adverse event was temporary dysesthesia representing 8.6%. 5 (6.1%) prostheses were revised and 1 (1.2%) was removed which lead to an implant survey of 92.7% at 5 years for all type of events. However, the survival rate is 97.6% if only device or procedure related events are counted. At five years of the 82 prosthesis, 92.7% are still placed, 4.9% had a component change and only 2.4% were converted to trapeziectomy.</div><div>The results show a persistence of clinical benefit at middle term with high satisfaction of patients. They regained and kept a strength thumb. 19 (23.2%) adverse events linked to the device procedure needed none or minor treatment and could all be resolved easily. The 5 (6.1%) major complications linked to the device or procedure were also resolved without difficulties. Of the six prostheses failure, only two were due to the device.</div><div>The double-mobility prosthesis is a reliable treatment of the CMC joint osteoarthrosis at middle term.</div></div>","PeriodicalId":54301,"journal":{"name":"Hand Surgery & Rehabilitation","volume":"43 6","pages":"Article 101821"},"PeriodicalIF":0.9000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hand Surgery & Rehabilitation","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468122924002524","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0
Abstract
Trapezometacarpal Osteoarthritis or rhizarthrosis, is a frequent osteoarthrosis of the base of the thumb. The total joint replacement represents an interesting surgical option for its treatment. The double-mobility Touch® prosthesis is available for several years and only few studies have been published to evaluate the safety and efficiency of this prosthesis in the long term. The objective of this study is to describe the outcomes of the Touch prosthesis for a minimal 5 years follow-up.
Patients who received a Touch prosthesis in the two investigational centers between March 2016 and July 2018, and with a 5 years follow up, were included in this retrospective and non-comparative study.
From 111 patients screened, 74 patients were included of which 8 had surgery at both sides. The mean age at the time of surgery was 62.4 (± 7.3) years. 62 (83.8%) were women and 51.2% of the patients had their dominant hand operated. The pain (VAS), Grip and Key pinch were significantly improved at five years follow-up. The quick DASH decreased from 55.1 to 14.6. The Kapandji opposition and retropulsion, the MCP active mobility flexion and extension improved. 91.3% of the patients are satisfied. 19 (23.2%) adverse events were minor and 8 (9.8%) were major. The most common adverse event was temporary dysesthesia representing 8.6%. 5 (6.1%) prostheses were revised and 1 (1.2%) was removed which lead to an implant survey of 92.7% at 5 years for all type of events. However, the survival rate is 97.6% if only device or procedure related events are counted. At five years of the 82 prosthesis, 92.7% are still placed, 4.9% had a component change and only 2.4% were converted to trapeziectomy.
The results show a persistence of clinical benefit at middle term with high satisfaction of patients. They regained and kept a strength thumb. 19 (23.2%) adverse events linked to the device procedure needed none or minor treatment and could all be resolved easily. The 5 (6.1%) major complications linked to the device or procedure were also resolved without difficulties. Of the six prostheses failure, only two were due to the device.
The double-mobility prosthesis is a reliable treatment of the CMC joint osteoarthrosis at middle term.
期刊介绍:
As the official publication of the French, Belgian and Swiss Societies for Surgery of the Hand, as well as of the French Society of Rehabilitation of the Hand & Upper Limb, ''Hand Surgery and Rehabilitation'' - formerly named "Chirurgie de la Main" - publishes original articles, literature reviews, technical notes, and clinical cases. It is indexed in the main international databases (including Medline). Initially a platform for French-speaking hand surgeons, the journal will now publish its articles in English to disseminate its author''s scientific findings more widely. The journal also includes a biannual supplement in French, the monograph of the French Society for Surgery of the Hand, where comprehensive reviews in the fields of hand, peripheral nerve and upper limb surgery are presented.
Organe officiel de la Société française de chirurgie de la main, de la Société française de Rééducation de la main (SFRM-GEMMSOR), de la Société suisse de chirurgie de la main et du Belgian Hand Group, indexée dans les grandes bases de données internationales (Medline, Embase, Pascal, Scopus), Hand Surgery and Rehabilitation - anciennement titrée Chirurgie de la main - publie des articles originaux, des revues de la littérature, des notes techniques, des cas clinique. Initialement plateforme d''expression francophone de la spécialité, la revue s''oriente désormais vers l''anglais pour devenir une référence scientifique et de formation de la spécialité en France et en Europe. Avec 6 publications en anglais par an, la revue comprend également un supplément biannuel, la monographie du GEM, où sont présentées en français, des mises au point complètes dans les domaines de la chirurgie de la main, des nerfs périphériques et du membre supérieur.